As of 2026-02-04, 乐泰可（瑞美吉泮）'s data on the DeepSeek platform in the 偏头痛急性治疗药物 category shows: The overall mention rate is 0.00%, below the industry average by 21.4 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
乐泰可（瑞美吉泮）'s Mention Rate is 0.00%, lower than 0.6% of competitors
乐泰可（瑞美吉泮）'s First Mention is 0.00%, lower than 0.9% of competitors
乐泰可（瑞美吉泮）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
乐泰可（瑞美吉泮）'s Positive Rate is 0.00%, lower than 8.9% of competitors
乐泰可（瑞美吉泮）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 乐乐泰可（瑞美吉泮） (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
